Cargando…

Clinical Characteristics Associated with Poor Prognosis of Acquired Immunodeficiency Syndrome Patients Complicated with Disseminated Talaromycosis marneffei

PURPOSE: To analyze the clinical characteristics of AIDS with dTSM, especially in patients with poor prognosis. PATIENTS AND METHODS: One hundred and seventy AIDS patients were enrolled in this single-center retrospective study. The epidemiological characteristics, clinical manifestations, laborator...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Lianpeng, Pan, Yong, Xu, Ke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10638893/ https://www.ncbi.nlm.nih.gov/pubmed/37954504 http://dx.doi.org/10.2147/IDR.S434695

Ejemplares similares

Clinical features of patients with talaromycosis marneffei and microbiological characteristics of the causative strains
por: Peng, Lei, et al.
Publicado: (2022)

Talaromyces marneffei Mp1p Antigen Detection may Play an Important Role in the Early Diagnosis of Talaromycosis in Patients with Acquired Immunodeficiency Syndrome
por: Chen, Xiaoman, et al.
Publicado: (2022)

Clinical features of HIV positive talaromycosis marneffei patients and development of a risk prediction model
por: Cen, Jiemei, et al.
Publicado: (2023)

Disseminated talaromycosis in an HIV-infected patient
por: Chang, Chee Yik, et al.
Publicado: (2021)

A case report of Talaromyces marneffei Oro-pharyngo-laryngitis: a rare manifestation of Talaromycosis
por: Wongkamhla, Thanyarak, et al.
Publicado: (2019)

Disseminated talaromycosis complicated by recurrent gastrointestinal bleeding and hemorrhagic shock: a case report
por: Cui, Xiaoya, et al.
Publicado: (2022)

Analysis of clinical characteristics and prognosis of talaromycosis (with or without human immunodeficiency virus) from a non-endemic area: a retrospective study
por: Shen, Qian, et al.
Publicado: (2021)

Disseminated Penicillium marneffei infection with IRIS
por: Liu, Xinchao, et al.
Publicado: (2015)

Clinical characteristics and risk factors for poor prognosis among HIV patients with Talaromyces marneffei bloodstream infection
por: Sun, Jianjun, et al.
Publicado: (2021)

The delayed clearance of Talaromyces marneffei in blood culture may be associated with higher MIC of voriconazole after antifungal therapy among AIDS patients with talaromycosis
por: Guo, Pengle, et al.
Publicado: (2023)

Disseminated toxoplasmosis in a patient with advanced acquired immunodeficiency syndrome
por: Pastorello, Ricardo Garcia, et al.
Publicado: (2018)

A Clinical Study of Acquired Immunodeficiency Syndrome Associated Penicillium Marneffei Infection from a Non-Endemic Area in China
por: Zheng, Jinding, et al.
Publicado: (2015)

HIV-child with disseminated Talaromyces Marneffei (Penicillium marneffei) infection: a rare severe case report
por: Hu, Wei, et al.
Publicado: (2022)

Disseminated Talaromyces marneffei in newly diagnosed HIV patient
por: Huang, Yingcai, et al.
Publicado: (2022)

Application of Flow Cytometry in the Diagnostics Pipeline of Primary Immunodeficiencies Underlying Disseminated Talaromyces marneffei Infection in HIV-Negative Children
por: Lee, Pamela P., et al.
Publicado: (2019)

Anti–IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections
por: Guo, Jing, et al.
Publicado: (2020)

Talaromycosis-Associated Secondary Hemophagocytic Lymphohistiocytosis in Nine Human Immunodeficiency Virus-Negative Patients: A Multicenter Retrospective Study
por: Pan, Mianluan, et al.
Publicado: (2019)

Immune Restoration Syndrome with disseminated Penicillium marneffei and Cytomegalovirus co-infections in an AIDS patient
por: Gupta, Swati, et al.
Publicado: (2007)

Prognosis and treatment effects of HIV-associated talaromycosis in a real-world patient cohort
por: Klus, Jonathan, et al.
Publicado: (2021)

Comparison of pleural effusion features and biomarkers between talaromycosis and tuberculosis in non-human immunodeficiency virus-infected patients
por: Qiu, Ye, et al.
Publicado: (2019)

Non-HIV talaromycosis: Radiological and clinical analysis
por: Li, Xinchun, et al.
Publicado: (2020)

Drug-related talaromycosis: A case report
por: Lu, Yongsheng, et al.
Publicado: (2020)

Advances in diagnosis and treatment of talaromycosis in patients with AIDS
por: Guo, Pengle, et al.
Publicado: (2022)

Case report: Hemophagocytic lymphohistiocytosis in a child with primary immunodeficiency infected with Talaromyces marneffei
por: Yan, Huimin, et al.
Publicado: (2022)

Determinants of prognosis in Talaromyces marneffei infections with respiratory system lesions
por: Qiu, Ye, et al.
Publicado: (2019)

Clinical Characteristics, Laboratory Findings, and Prognosis in Patients With Talaromyces marneffei Infection Across Various Immune Statuses
por: Li, Dianwu, et al.
Publicado: (2022)

Hemophagocytic lymphohistiocytosis (HLH) secondary to disseminated histoplasmosis in the setting of Acquired Immunodeficiency Syndrome (AIDS)
por: Asanad, Samuel, et al.
Publicado: (2018)

Fatal disseminated cytomegalovirus infection with necrotizing oophoritis in a patient with acquired immunodeficiency syndrome
por: Soares, Laís Braga, et al.
Publicado: (2018)

Talaromycosis in a Patient on Nintedanib for Interstitial Lung Disease
por: Madgula, Anantha Sriharsha, et al.
Publicado: (2020)

Pulmonary Talaromycosis: A Window into the Immunopathogenesis of an Endemic Mycosis
por: Narayanasamy, Shanti, et al.
Publicado: (2021)

An Overview of Diagnostic and Management Strategies for Talaromycosis, an Underrated Disease
por: Zaongo, Silvere D., et al.
Publicado: (2023)

Rare incidence of non-secretory myeloma with talaromycosis: a case report
por: Qin, Haiting, et al.
Publicado: (2021)

Retrospective analysis of 14 cases of disseminated Penicillium marneffei infection with osteolytic lesions
por: Qiu, Ye, et al.
Publicado: (2015)

Population Pharmacodynamics of Amphotericin B Deoxycholate for Disseminated Infection Caused by Talaromyces marneffei
por: Le, Thuy, et al.
Publicado: (2019)

Disseminated Coinfection by Mycobacterium fortuitum and Talaromyces marneffei in a Non-HIV Case
por: Huang, Hongchun, et al.
Publicado: (2021)

Cost-Effectiveness of Amphotericin B Deoxycholate Versus Itraconazole for Induction Therapy of Talaromycosis in Human Immunodeficiency Virus–Infected Adults in Vietnam
por: Buchanan, James, et al.
Publicado: (2021)

Disseminated Talaromyces marneffei infection after renal transplantation: A case report and literature review
por: Xu, Liang, et al.
Publicado: (2023)

Disseminated Histoplasmosis in a Patient With Acquired Immunodeficiency Syndrome in a Non-Endemic Region (California)
por: Phan, Alexander T., et al.
Publicado: (2023)

Characterization of Anti–Interferon-γ Antibodies in HIV-Negative Patients Infected With Disseminated Talaromyces marneffei and Cryptococcosis
por: Zeng, Wen, et al.
Publicado: (2019)

Talaromyces marneffei
por: Mahajan, Monika
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_5mp00ifv5u5l85pc28m4v1859t